Prospective Study
Copyright ©The Author(s) 2015.
World J Hepatol. Jun 18, 2015; 7(11): 1586-1594
Published online Jun 18, 2015. doi: 10.4254/wjh.v7.i11.1586
Table 2 Summary of the characteristics of participants (n = 442)
Characteristics
Age (yr)49.1 ± 14.2
Gender
Female290 (65.6)
Male152 (34.4)
BMI (kg/m2)31.3 ± 6.1
Hepatic steatosis230 (52.0)
Elevated ALT1128 (29.0)
Elevated AST2129 (29.2)
Albumin (g/dL)4.0 (3.8-4.2)
Platelet (109/μL)243.5 (207.0-282.0)
DM397 (21.9)
Hypertension167 (37.8)
Hyperglycemia134 (30.3)
Hypertriglyceridemia175 (39.6)
Low HDL-C267 (60.4)
Central obesity324 (73.3)
Metabolic syndrome219 (49.5)
NAFLD fibrosis score
< -1.455244 (55.2)
-1.455-0.676169 (38.2)
> 0.67629 (6.6)
FIB4 index
≤ 1.31323 (73.1)
1.31-2.66106 (24.0)
≥ 2.6713 (2.9)
BARD
0-1163 (36.9)
2-4279 (63.1)
APRI
≤ 0.5365 (82.6)
0.51-1.573 (16.5)
> 1.54 (0.9)